1. Discovery of the imidazole-derived GPR40 agonist AM-3189. Issue 1 (1st January 2016) Authors: Ma, Zhihua; Lin, Daniel C.-H.; Sharma, Rajiv; Liu, Jinqian; Zhu, Liusheng; Li, An-Rong; Kohn, Todd; Wang, Yingcai; Liu, Jiwen (Jim); Bartberger, Michael D.; Medina, Julio C.; Zhuang, Run; Li, Frank; Zhang, Jane; Luo, Jian; Wong, Simon; Tonn, George R.; Houze, Jonathan B. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 26:Issue 1(2016) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers. Issue 2 (25th September 2019) Authors: Grievink, Hendrika W.; Heuberger, Jules A.A.C.; Huang, Fen; Chaudhary, Rinkal; Birkhoff, Willem A.J.; Tonn, George R.; Mosesova, Sofia; Erickson, Rebecca; Moerland, Matthijs; Haddick, Patrick C.G.; Scearce‐Levie, Kimberly; Ho, Carole; Groeneveld, Geert Jan Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 2(2020) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗